Massachusetts Financial Services Co. MA decreased its stake in Inspire Medical Systems (NYSE:INSP) by 0.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 171,800 shares of the company’s stock after selling 647 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Inspire Medical Systems were worth $10,483,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Inspire Medical Systems by 293.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 637 shares of the company’s stock worth $39,000 after purchasing an additional 475 shares during the period. Marshall Wace North America L.P. acquired a new stake in shares of Inspire Medical Systems during the first quarter worth about $45,000. Royal Bank of Canada raised its position in shares of Inspire Medical Systems by 593.3% during the second quarter. Royal Bank of Canada now owns 1,040 shares of the company’s stock worth $63,000 after purchasing an additional 890 shares during the period. Advisory Services Network LLC raised its position in shares of Inspire Medical Systems by 24.6% during the second quarter. Advisory Services Network LLC now owns 1,395 shares of the company’s stock worth $85,000 after purchasing an additional 275 shares during the period. Finally, First Quadrant L P CA acquired a new stake in shares of Inspire Medical Systems during the second quarter worth about $118,000. 86.57% of the stock is currently owned by hedge funds and other institutional investors.
NYSE:INSP opened at $63.99 on Monday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 13.05 and a current ratio of 13.42. The company has a market cap of $1.52 billion, a PE ratio of -42.66 and a beta of 1.22. Inspire Medical Systems has a 52-week low of $35.43 and a 52-week high of $71.71. The stock has a 50-day simple moving average of $58.65 and a 200 day simple moving average of $60.59.
A number of equities research analysts have recently commented on the company. Dougherty & Co set a $78.00 price target on Inspire Medical Systems and gave the stock a “buy” rating in a research report on Friday, September 27th. Zacks Investment Research raised Inspire Medical Systems from a “hold” rating to a “strong-buy” rating and set a $69.00 price target on the stock in a research report on Saturday, November 9th. ValuEngine lowered Inspire Medical Systems from a “hold” rating to a “sell” rating in a research report on Thursday, October 31st. Finally, Berenberg Bank raised Inspire Medical Systems from a “sell” rating to a “hold” rating and raised their price target for the stock from $46.00 to $51.00 in a research report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $68.25.
In other Inspire Medical Systems news, CEO Timothy P. Herbert sold 15,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $65.96, for a total value of $989,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Randy Ban sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $61.62, for a total value of $616,200.00. Over the last quarter, insiders have sold 185,550 shares of company stock valued at $12,016,651. 12.10% of the stock is owned by corporate insiders.
Inspire Medical Systems Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Recommended Story: Investing in Dividend Stocks
Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems (NYSE:INSP).
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
